Contact
Submit the intake brief.
Tell us who you are, what you source, and where your supply chain stands today. TEKMERIS reviews every brief internally — counterparty risk, product category, and protocol alignment — and responds by email within 48 hours if your engagement criteria align with our mandate.
Engagement Structure
Phase-Gated. Discovery Is the Deliverable.
Phase 0: Vetting (billed standalone)
Counterparty forensics and registry matching. The finding belongs to you whether or not the engagement proceeds.
Trace-Through Audit (quoted after discovery)
If the true manufacturer is disclosed and access is granted, full verification is quoted at the production site, with the intermediary's contract chain reviewed as part of scope.
Limited-Scope Custody Verification (where production access is impossible)
A clearly labelled, lower-scope product covering warehouse custody, cold chain, and inventory sampling. The report states its limitation on the cover page. It is never presented as a production audit.
Written Decline
Where neither is possible, we decline in writing, and you keep the vetting findings.
Responsibilities at a Glance
TEKMERIS verifies batch integrity and factory provenance at the point of origin. The Client remains the sole Importer of Record. Customs clearance, import permits (FDA/TGA/MHRA), and border seizure liability are the sole responsibility of the Client.
Email the right desk
The intake brief is the fastest route — it reaches the audits desk and is reviewed in writing. To write to a specific desk instead:
- Audits & engagement enquiries — include what you source and rough monthly volume.
- General enquiries
- Partners & laboratories
Tekmeris Global does not provide medical, therapeutic, or dosage guidance by email or on calls. Verification enquiries only.